A breath fungal secondary metabolite signature to diagnose invasive aspergillosis

Clinical Infectious Diseases

Volumn 59, Issue 12, 2014, Pages 1733-1740

  Koo, Sophia ^a,b,c   Thomas, Horatio R ^a,c   Daniels, S David ^a   Lynch, Robert C ^a   Fortier, Sean M ^a   Shea, Margaret M ^a   Rearden, Preshious ^d   Comolli, James C ^d   Baden, Lindsey R ^a,b,c   Marty, Francisco M ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CHARLES STARK DRAPER LABORATORY   (United States)

Author keywords

aspergillosis; breath; diagnostics; fungal infection; volatile organic compounds

Indexed keywords

AMPHOTERICIN; BETA PINENE; FUNGUS ANTIGEN; GALACTOMANNAN; LIMONENE; MICAFUNGIN; PINENE; SESQUITERPENE DERIVATIVE; TERPENE DERIVATIVE; VORICONAZOLE; ALPHA-PINENE; BETA-PINENE; BICYCLO COMPOUND; CAMPHENE; CYCLOHEXENE DERIVATIVE; SESQUITERPENE; TERPENE;

ADULT; AGED; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; BREATHING; DESORPTION; DRUG EXPOSURE; FEMALE; FUNGUS GROWTH; FUNGUS HYPHAE; HEMATOLOGIC MALIGNANCY; HOST; HUMAN; IN VITRO STUDY; INVASIVE ASPERGILLOSIS; LUNG MYCOSIS; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; PRIORITY JOURNAL; RISK FACTOR; ASPERGILLOSIS; METABOLISM; MIDDLE AGED; PATHOGENICITY; PROSPECTIVE STUDY;

ADULT; AGED; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BICYCLO COMPOUNDS; CYCLOHEXENES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MIDDLE AGED; MONOTERPENES; PROSPECTIVE STUDIES; SESQUITERPENES; TERPENES;

EID: 84924952838     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu725     Document Type: Article

References (40)

1. Hammond SP, Marty FM, Bryar JM, DeAngelo DJ, Baden LR. Invasive fungal disease in patients treated for newly diagnosed acute leukemia. Am J Hematol 2010; 85:695-9.
2. Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50:1091-100.
3. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18:44-69.
4. Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50:1101-11.
5. Neofytos D, Horn D, Anaissie E, et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009; 48:265-73.
6. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32:358-66.
7. Segal BH. Aspergillosis. N Engl J Med 2009; 360:1870-84.
8. Greene RE, Schlamm HT, Oestmann JW, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis 2007; 44:373-9.
9. Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001; 33:1824-33.
10. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5:609-22.
11. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42: 1417.27.
12. Koo S, Bryar JM, Page JH, Baden LR, Marty FM. Diagnostic performance of the (1,3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis 2009; 49:1650.9.
13. Harrison E, Stalhberger T, Whelan R, et al. Aspergillus DNA contamination in blood collection tubes. Diagn Microbiol Infect Dis 2010; 67:392.4.
14. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9:89.96.
15. Keller NP, Turner G, Bennett JW. Fungal secondary metabolism.from biochemistry to genomics. Nat Rev Microbiol 2005; 3:937.47.
16. Kramer R, Abraham W-R. Volatile sesquiterpenes from fungi: what are they good for? Phytochem Rev 2012; 11:15.37.
17. Frisvad JC, Rank C, Nielsen KF, Larsen TO. Metabolomics of Aspergillus fumigatus. Med Mycol 2009; (suppl 1):S53.71.
18. McDonagh A, Fedorova ND, Crabtree J, et al. Sub-telomere directed gene expression during initiation of invasive aspergillosis. PLoS Pathog 2008; 4:e1000154.
19. Gershenzon J, Dudareva N. The function of terpene natural products in the natural world. Nat Chem Biol 2007; 3:408.14.
20. Fiedler K, Schutz E, Geh S. Detection of microbial volatile organic compounds (MVOCs) produced by moulds on various materials. Int J Hyg Environ Health 2001; 204:111.21.
21. Perl T, Junger M, VautzW, et al. Detection of characteristic metabolites of Aspergillus fumigatus and Candida species using ion mobility spectrometry. metabolic profiling by volatile organic compounds. Mycoses 2011; 54:e828.37.
22. Gao P, Korley F, Martin J, Chen BT. Determination of unique microbial volatile organic compounds produced by five Aspergillus species commonly found in problem buildings. AIHA J (Fairfax, Va) 2002; 63: 135.40.
23. Syhre M, Scotter JM, Chambers ST. Investigation into the production of 2-pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples. Med Mycol 2008; 46:209.15.
24. Balajee SA, Kano R, Baddley JW, et al. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol 2009; 47:3138.41.
25. Baddley JW, Marr KA, Andes DR, et al. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol 2009; 47:3271.5.
26. Brakhage AA. Regulation of fungal secondary metabolism. Nat Rev Microbiol 2013; 11:21.32.
27. Pontecorvo G, Roper JA, Hemmons LM, Macdonald KD, Bufton AWJ. The genetics of Aspergillus nidulans. Adv Genet 1953; 5:141.238.
28. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813.21.
29. Warnes G, Bolker B, Bonebakker L, Gentleman R, Liaw WHA, Lumley T. gplots: various R programming tools for plotting data. The Comprehensive R Archive Network, 2009. Available at: http://cran.r-project. org/package=gplots. Accessed September 2014.
30. Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 1991; 44:763.70.
31. Sethi S, Nanda R, Chakraborty T. Clinical application of volatile organic compound analysis for detecting infectious diseases. Clin Microbiol Rev 2013; 26:462.75.
32. Kwak J, Preti G. Volatile disease biomarkers in breath: a critique. Curr Pharm Biotechnol 2011; 12:1067.74.
33. Chambers ST, Bhandari S, Scott-Thomas A, SyhreM. Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus. Med Mycol 2011; 49:S54.61.
34. Lin J, Li M, XuW, et al. Techniques in infectious diseases: identification of unique volatile compounds of Aspergillus fumigatus for potential diagnostic breath test by HS-SPME and GC-MS. J Immunol Tech Infect Dis 2013; 2:3.
35. Baggerly KA, Morris JS, Edmonson SR, Coombes KR. Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J Natl Cancer Inst 2005; 97:307.9.
36. Bazemore RA, Feng J, Cseke L, Podila GK. Biomedically important pathogenic fungi detection with volatile biomarkers. J Breath Res 2012; 6:016002.
37. Heddergott C, Calvo AM, Latge JP. The volatome of Aspergillus fumigatus. Eukaryot Cell 2014; 13:1014.25.
38. Nozoe S, Kobayashi H, Morisaki N. Isolation of b-trans-bergamotene from Aspergillus fumigatus, a fumagillin producing fungi. Tetrahedron Lett 1976; 50:4625.6.
39. Lin H-C, Chooi Y-H, Dhingra S, Xu W, Calvo AM, Tang Y. The fumagillin biosynthetic gene cluster in Aspergillus fumigatus encodes a cryptic terpene cyclase involved in the formation of ?À-trans-bergamotene. J Am Chem Soc 2013; 135:4616.9.
40. Christianson DW. Chemistry. Roots of biosynthetic diversity. Science 2007; 316:60.1.